Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 13Sexual Dysfunction, Physiological 6Breast Neoplasms 5Overweight 4Neoplasms 4Mucositis 3Endometrial Neoplasms 3Cancer-related Fatigue 3Sexual Dysfunctions, Psychological 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Motor Activity 2Leukemia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Constipation 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pituitary Neoplasms 1Pediatric Obesity 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Hyperplasia × Other × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡